David M Taylor (David Taylor)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 71

Top Topics

Systematic Review

Bipolar Disorder

Cross Sectional

Top Venues

Therapeutic advances in psychopharmacology

Journal of psychopharmacology (Oxford, England)

Psychopharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Ivana Clark, Phoebe Wallman, Siobhan Helen Gee, David M Taylor
Long term impact of 3-monthly paliperidone palmitate on hospitalisation in patients with schizophrenia: Six-year mirror image study. Acta psychiatrica Scandinavica 150 (1) (2024)
David M Taylor, Sofia Poulou, Ivana Clark
The cardiovascular safety of tricyclic antidepressants in overdose and in clinical use. Therapeutic advances in psychopharmacology 14 (2024)
Ivana Clark, Phoebe Wallman, Siobhan Helen Gee, David M Taylor
Long term impact of 3-monthly paliperidone palmitate on hospitalisation in patients with schizophrenia: Six-year mirror image study. Acta psychiatrica Scandinavica (2024)
Ebenezer Oloyede, Christian J Bachmann, Olubanke Dzahini, Juan Miguel Lopez Alcaraz, Shaurya Dev Singh, Kalliopi Vallianatu, Burkhardt Funk, Eromona Whiskey, David M Taylor
Identifying clinically relevant agranulocytosis in people registered on the UK clozapine Central Non-Rechallenge Database: retrospective cohort study. The British journal of psychiatry : the journal of mental science (2024)
Ivana Clark, Phoebe Wallman, Siobhan Helen Gee, David M Taylor
Clinical outcomes with paliperidone palmitate 3-monthly injection as monotherapy: observational 3-year follow-up of patients with schizophrenia. European psychiatry : the journal of the Association of European Psychiatrists 67 (1) (2024)
Ivana Clark, Phoebe Wallman, Siobhan Helen Gee, David M Taylor
Long term impact of 3-monthly paliperidone palmitate on hospitalisation in patients with schizophrenia: Six-year mirror image study. Acta psychiatrica Scandinavica 150 (1) (2024)
Anne Connolly, Phoebe Wallman, Olubanke Dzahini, Oliver Howes, David M Taylor
Meta-analysis and systematic review of vesicular monoamine transporter (VMAT-2) inhibitors in schizophrenia and psychosis. Psychopharmacology 241 (2) (2024)
Anne Connolly, Phoebe Wallman, Olubanke Dzahini, Oliver Howes, David M Taylor
Meta-analysis and systematic review of vesicular monoamine transporter (VMAT-2) inhibitors in schizophrenia and psychosis. Psychopharmacology 241 (2) (2024)
Ivana Clark, Phoebe Wallman, Siobhan Helen Gee, David M Taylor
Clinical outcomes with paliperidone palmitate 3-monthly injection as monotherapy: observational 3-year follow-up of patients with schizophrenia. European psychiatry : the journal of the Association of European Psychiatrists 67 (1) (2024)
Ivana Clark, Phoebe Wallman, Siobhan Helen Gee, David M Taylor
Clinical outcomes with paliperidone palmitate 3-monthly injection as monotherapy: observational 3-year follow-up of patients with schizophrenia. European psychiatry : the journal of the Association of European Psychiatrists 67 (1) (2024)
Anne Connolly, Phoebe Wallman, Olubanke Dzahini, Oliver Howes, David M Taylor
Meta-analysis and systematic review of vesicular monoamine transporter (VMAT-2) inhibitors in schizophrenia and psychosis. Psychopharmacology 241 (2) (2024)
Anne Connolly, Phoebe Wallman, Olubanke Dzahini, Oliver Howes, David M Taylor
Meta-analysis and systematic review of vesicular monoamine transporter (VMAT-2) inhibitors in schizophrenia and psychosis. Psychopharmacology 241 (2) (2024)
Ivana Clark, Phoebe Wallman, Siobhan Helen Gee, David M Taylor
Long term impact of 3-monthly paliperidone palmitate on hospitalisation in patients with schizophrenia: Six-year mirror image study. Acta psychiatrica Scandinavica 150 (1) (2024)
Anne Connolly, Phoebe Wallman, Olubanke Dzahini, Oliver Howes, David M Taylor
Meta-analysis and systematic review of vesicular monoamine transporter (VMAT-2) inhibitors in schizophrenia and psychosis. Psychopharmacology 241 (2) (2024)
James R O'Neill, David M Taylor, Mark A Horowitz
Using in silico methods to determine optimal tapering regimens for decanoate-based long-acting injectable psychosis drugs. Therapeutic advances in psychopharmacology 14 (2024)
David M Taylor, Kalliopi Vallianatou, Shreyans Gandhi, Cecilia Casetta, Oliver Howes, James Hunter MacCabe
Severe neutropenia unrelated to clozapine in patients receiving clozapine. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
Anne Connolly, Phoebe Wallman, Olubanke Dzahini, Oliver Howes, David M Taylor
Meta-analysis and systematic review of vesicular monoamine transporter (VMAT-2) inhibitors in schizophrenia and psychosis. Psychopharmacology (2024)
David M Taylor, Kalliopi Vallianatou, Shreyans Gandhi, Cecilia Casetta, Oliver Howes, James Hunter MacCabe
Severe neutropenia unrelated to clozapine in patients receiving clozapine. Journal of psychopharmacology (Oxford, England) (2024)
David M Taylor, Sofia Poulou, Ivana Clark
The cardiovascular safety of tricyclic antidepressants in overdose and in clinical use. Therapeutic advances in psychopharmacology 14 (2024)
Ivana Clark, Phoebe Wallman, Siobhan Helen Gee, David M Taylor
Clinical outcomes with paliperidone palmitate 3-monthly injection as monotherapy: observational 3-year follow-up of patients with schizophrenia. European psychiatry : the journal of the Association of European Psychiatrists 67 (1) (2024)
Matthew Atkins, David M Taylor, Ana Catalan, Neville Desouza, Edward Chesney, Thomas J Reilly, Irina Baburina, Mary Rose Hilaire, Luiz Dratcu, Robert Harland, Salvatore J Salamone, Philip K McGuire
Point of care assay for blood aripiprazole concentrations: development, validation and utility. The British journal of psychiatry : the journal of mental science (2023)
Ebenezer Oloyede, Graham Blackman, Bethany Mantell, Eleanor Harris, Julie Williams, David M Taylor, James Hunter MacCabe, Philip K McGuire
What are the barriers and facilitators of clozapine use in early psychosis? A survey of UK early intervention clinicians. Schizophrenia (Heidelberg, Germany) 9 (1) (2023)
David M Taylor, Koichiro Watanabe
Tardive dyskinesia: understanding current challenges in diagnosis and treatment. Therapeutic advances in psychopharmacology 13 (2023)
Ebenezer Oloyede, Olubanke Dzahini, Zadro Abolou, Siobhan Gee, Eromona Whiskey, Diksha Malhotra, Masuma Hussain, Ian Osborne, Cecilia Casetta, Philip K McGuire, James Hunter MacCabe, David M Taylor
Clinical impact of reducing the frequency of clozapine monitoring: controlled mirror-image cohort study. The British journal of psychiatry : the journal of mental science (2023)
Yuya Mizuno, Devi L Bridglal, Jack Coumbe, Hari McGrath, Ayush Adhikari, Emma Butler, Ilaria Bonoldi, David M Taylor, Oliver D Howes
Low-frequency monitoring for community clozapine initiations: A comparative study relative to standard frequency assessments. Journal of psychopharmacology (Oxford, England) (2023)
Ebenezer Oloyede, Graham Blackman, Bethany Mantell, Eleanor Harris, Julie Williams, David M Taylor, James Hunter MacCabe, Philip K McGuire
What are the barriers and facilitators of clozapine use in early psychosis? A survey of UK early intervention clinicians. Schizophrenia (Heidelberg, Germany) 9 (1) (2023)
Ebenezer Oloyede, Olubanke Dzahini, Zadro Abolou, Siobhan Gee, Eromona Whiskey, Diksha Malhotra, Masuma Hussain, Ian Osborne, Cecilia Casetta, Philip K McGuire, James Hunter MacCabe, David M Taylor
Clinical impact of reducing the frequency of clozapine monitoring: controlled mirror-image cohort study. The British journal of psychiatry : the journal of mental science (2023)
Caroline S Copeland, Phoebe Wallman, David Morgan, Eleanor Owen, David M Taylor
A case-control study of antipsychotic use and pneumonia-related mortality in the United Kingdom. Acta psychiatrica Scandinavica 147 (3) (2023)
Delia Bishara, Sahar Riaz, Justin Sauer, Christopher Mueller, Siobhan Gee, David M Taylor, Robyn-Jenia Wilcha, Millie Edwards, Nirja Beehuspoteea, Anne Marie Bonnici Mallia, Jennifer Brook, Bharathi Balasundaram, Daniel Harwood, Nicola Funnell, Andre Strydom, Robert J Stewart
A tool for safer prescribing in vulnerable adults: the continuing development of the Medichec app and website. BJPsych bulletin (2023)
Ebenezer Oloyede, Olubanke Dzahini, Zadro Abolou, Siobhan Gee, Eromona Whiskey, Diksha Malhotra, Masuma Hussain, Ian Osborne, Cecilia Casetta, Philip K McGuire, James Hunter MacCabe, David M Taylor
Clinical impact of reducing the frequency of clozapine monitoring: controlled mirror-image cohort study. The British journal of psychiatry : the journal of mental science (2023)
James R O'Neill, David M Taylor, Mark A Horowitz
Implementing gradual, hyperbolic tapering of long-acting injectable antipsychotics by prolonging the inter-dose interval: an in silico modelling study. Therapeutic advances in psychopharmacology 13 (2023)
David M Taylor, Caroline Cahill, Paul Wallang, Louise Millard, Luis Ramudo Cela, Kieran C Breen
Predicting clozapine dose required to achieve a therapeutic plasma concentration - A comparison of a population algorithm and three algorithms based on gene variant models. Journal of psychopharmacology (Oxford, England) (2023)
Ebenezer Oloyede, Graham Blackman, Bethany Mantell, Eleanor Harris, Julie Williams, David M Taylor, James Hunter MacCabe, Philip K McGuire
What are the barriers and facilitators of clozapine use in early psychosis? A survey of UK early intervention clinicians. Schizophrenia (Heidelberg, Germany) 9 (1) (2023)
Caroline S Copeland, Phoebe Wallman, David Morgan, Eleanor Owen, David M Taylor
A case-control study of antipsychotic use and pneumonia-related mortality in the United Kingdom. Acta psychiatrica Scandinavica 147 (3) (2023)
Ebenezer Oloyede, Graham Blackman, Bethany Mantell, Eleanor Harris, Julie Williams, David M Taylor, James Hunter MacCabe, Philip K McGuire
What are the barriers and facilitators of clozapine use in early psychosis? A survey of UK early intervention clinicians. Schizophrenia (Heidelberg, Germany) 9 (1) (2023)
Ebenezer Oloyede, Bethany Mantell, Julie Williams, Serena Lai, Sameer Jauhar, David M Taylor, James H MacCabe, Robert Harland, Philip McGuire, Graham Blackman
Clozapine for treatment resistance in early psychosis: a survey of UK clinicians' training, knowledge and confidence. Therapeutic advances in psychopharmacology 12 (2022)
Mark Abie Horowitz, Adele Framer, Michael P Hengartner, Anders Sørensen, David M Taylor
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data. CNS drugs (2022)
Shubhra Mace, Olubanke Dzahini, Victoria Cornelius, Hadar Langerman, Ebenezer Oloyede, David M Taylor
Incident infection during the first year of treatment - A comparison of clozapine and paliperidone palmitate long-acting injection. Journal of psychopharmacology (Oxford, England) 36 (2) (2022)
Mark Abie Horowitz, Adele Framer, Michael P Hengartner, Anders Sørensen, David M Taylor
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data. CNS drugs 37 (2) (2022)
Azizah Attard, John Wakelam, Josephine Broyd, David M Taylor, Jonathan Hafferty
Olanzapine long-acting injection, discontinuation rates and reasons for discontinuation: 10 years' experience at a UK high-secure hospital. Therapeutic advances in psychopharmacology 12 (2022)
Mark Abie Horowitz, Adele Framer, Michael P Hengartner, Anders Sørensen, David M Taylor
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data. CNS drugs 37 (2) (2022)
Mark Abie Horowitz, Adele Framer, Michael P Hengartner, Anders Sørensen, David M Taylor
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data. CNS drugs 37 (2) (2022)
Mark Abie Horowitz, Adele Framer, Michael P Hengartner, Anders Sørensen, David M Taylor
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data. CNS drugs 37 (2) (2022)
Ebenezer Oloyede, Ivana Clark, Shubhra Mace, Eromona Whiskey, David M Taylor
Clozapine augmentation with cariprazine for negative symptoms: a case series and literature review. Therapeutic advances in psychopharmacology 12 (2022)
Nicola J Kalk, Ching-Ting Chiu, Rasa Sadoughi, Heli Baho, Bryn D Williams, David M Taylor, Caroline S Copeland
Fatalities associated with gabapentinoids in England (2004-2020). British journal of clinical pharmacology 88 (8) (2022)
Sofia Brissos, David M Taylor
Weekly Supervised Administration of Oral Antipsychotics: An Alternative to Long-Acting Injections? CNS drugs 36 (4) (2022)
Mark Abie Horowitz, Adele Framer, Michael P Hengartner, Anders Sørensen, David M Taylor
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data. CNS drugs 37 (2) (2022)
David M Taylor, Kalliopi Vallianatou, Eromona Whiskey, Olubanke Dzahini, James MacCabe
Distinctive pattern of neutrophil count change in clozapine-associated, life-threatening agranulocytosis. Schizophrenia (Heidelberg, Germany) 8 (1) (2022)
Ebenezer Oloyede, Bethany Mantell, Julie Williams, Serena Lai, Sameer Jauhar, David M Taylor, James H MacCabe, Robert Harland, Philip McGuire, Graham Blackman
Clozapine for treatment resistance in early psychosis: a survey of UK clinicians' training, knowledge and confidence. Therapeutic advances in psychopharmacology 12 (2022)
Siobhan Helen Gee, Vasco Almeida, Adam Hughes, Isabel McMullen, David M Taylor
Reasons for admission to a general medical hospital for patients taking clozapine. Therapeutic advances in psychopharmacology 12 (2022)
Siobhan Helen Gee, Vasco Almeida, Adam Hughes, Isabel McMullen, David M Taylor
Reasons for admission to a general medical hospital for patients taking clozapine. Therapeutic advances in psychopharmacology 12 (2022)
Emma Butler, Toby Pillinger, Kirsten Brown, Faith Borgan, Alice Bowen, Katherine Beck, Enrico D'Ambrosio, Lisa Donaldson, Sameer Jauhar, Stephen Kaar, Tiago Reis Marques, Robert A McCutcheon, Maria Rogdaki, Fiona Gaughran, James Hunter MacCabe, Rosalind Ramsay, David M Taylor, Paul McCrone, Alice Egerton, Oliver D Howes
Real-world clinical and cost-effectiveness of community clozapine initiation: mirror cohort study. The British journal of psychiatry : the journal of mental science 221 (6) (2022)
Mark Abie Horowitz, Adele Framer, Michael P Hengartner, Anders Sørensen, David M Taylor
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data. CNS drugs 37 (2) (2022)
Thomas J Reilly, Phoebe Wallman, Ivana Clark, Clare-Louise Knox, Michael C Craig, David M Taylor
Intermittent selective serotonin reuptake inhibitors for premenstrual syndromes: A systematic review and meta-analysis of randomised trials. Journal of psychopharmacology (Oxford, England) (2022)
Ursula Werneke, Fiona Gaughran, David M Taylor
Vitamin D in the time of the coronavirus (COVID-19) pandemic - a clinical review from a public health and public mental health perspective. Therapeutic advances in psychopharmacology 11 (2021)
Eromona Whiskey, Graziella Romano, Matilda Elliott, Malcolm Campbell, Cholan Anandarajah, David M Taylor, Koravangattu Valsraj
Possible pharmacogenetic factors in clozapine treatment failure: a case report. Therapeutic advances in psychopharmacology 11 (2021)
Ivana Clark, Phoebe Wallman, Victoria R Cornelius, David M Taylor
Factors predicting relapse and treatment discontinuation with paliperidone 3-monthly long-acting injection: A 2-year naturalistic follow-up study. European psychiatry : the journal of the Association of European Psychiatrists 64 (1) (2021)
Danielle Dunnett, Ebenezer Oloyede, Oluwakemi Oduniyi, Barbara Arroyo, Olubanke Dzahini, David M Taylor, Sukhi S Shergill, Eromona Whiskey
Evaluation of the effectiveness and acceptability of the long-acting oral antipsychotic penfluridol: Illustrative case series. Journal of psychopharmacology (Oxford, England) (2021)
David M Taylor, Matthew Atkins, Robert Harland, Irina Baburina, James H MacCabe, Salvatore J Salamone, Philip McGuire
Point-of-care measurement of clozapine concentration using a finger-stick blood sample. Journal of psychopharmacology (Oxford, England) 35 (3) (2021)
Matthew Atkins, Philip McGuire, Bhirundra Balgobin, Pravinkumar Patel, David M Taylor
Using a fingerstick test for haematological monitoring in patients treated with clozapine. Therapeutic advances in psychopharmacology 11 (2021)
Emily Laing, David M Taylor
Relapse and frequency of injection of monthly paliperidone palmitate-A retrospective case-control study. European psychiatry : the journal of the Association of European Psychiatrists 64 (1) (2021)
Phoebe Wallman, Ivana Clark, David M Taylor
Discontinuation and relapse with paliperidone palmitate three-monthly for maintenance of schizophrenia: Two year follow-up of use in clinical practice. Journal of psychopharmacology (Oxford, England) 35 (9) (2021)
Adrian H Heald, David Holland, Michael Stedman, Mark Davies, Chris J Duff, Ceri Parfitt, Lewis Green, Jonathan Scargill, David M Taylor, Anthony A Fryer
Can we check serum lithium levels less often without compromising patient safety? BJPsych open 8 (1) (2021)
Eromona Whiskey, Shirley Yuen, Emma Khosla, Susan Piper, David O'Flynn, David M Taylor
Resolution without discontinuation: heart failure during clozapine treatment. Therapeutic advances in psychopharmacology 10 (2020)
David M Taylor, Mark Abie Horowitz
Antipsychotics and mortality - more clarity needed. Psychological medicine 50 (16) (2020)
Delia Bishara, Chris Kalafatis, David M Taylor
Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents. Therapeutic advances in psychopharmacology 10 (2020)
Siobhan Helen Gee, David M Taylor
The effect of COVID-19 on absolute neutrophil counts in patients taking clozapine. Therapeutic advances in psychopharmacology 10 (2020)
Siobhan Helen Gee, Fiona Gaughran, James MacCabe, Sukhi Shergill, Eromona Whiskey, David M Taylor
Management of clozapine treatment during the COVID-19 pandemic. Therapeutic advances in psychopharmacology 10 (2020)
Farinaz Keshavarzi, Tony Fox, Eromona Whiskey, David M Taylor
Change in plasma concentration of clozapine and norclozapine following a switch of oral formulation. Therapeutic advances in psychopharmacology 10 (2020)
Matthew Butler, Felicity Bano, Marilia Calcia, Isabel McMullen, Chun Chiang Sin Fai Lam, Laura Jane Smith, David M Taylor, Siobhan Helen Gee
Clozapine prescribing in COVID-19 positive medical inpatients: a case series. Therapeutic advances in psychopharmacology 10 (2020)
Giovanni Ostuzzi, Chiara Gastaldon, Davide Papola, Andrea Fagiolini, Serdar Dursun, David M Taylor, Christoph U Correll, Corrado Barbui
Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches. Therapeutic advances in psychopharmacology 10 (2020)